IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action

• المؤلفون الرئيسيون: Lecour, Sandrine, Andreadou, Ioanna, Bøtker, H.E., Davidson, Sean M., Heusch, Gerd, Ruiz-Meana, Marisol, Schulz, Rainer, Zuurbier, Coert J., Ferdinandy, Peter, Hausenloy, Derek J., Adamovski, P., Batirel, S., Barteková, M., Bertrand, L., Beauloye, C., Biedermann, D., Borutaite, V., Chlopicki, S., Dambrova, M., Devaux, Y., Di Lisa, F., Djuric, D., Erlinge, D., Falcao-Pires, I., Galatou, E., Garcia-Sosa, A., Girao, H., Giricz, Z., Gyongyosi, M., Healy, D., Jakovljevic, V., Jovanic, J., Kararigas, G., Kerkal, R., Kolar, F., Kwak, B., Leszek, P., Liepinsh, E., Lonborg, J., Longnus, S., Marinovic, J., Muntean, D.M., Nezic, L., Ovize, M., Pagliaro, P., Da Costa Gomes, C.P., Pernow, J., Persidis, A., Pischke, S.E., Podesser, B., Poto?njak, I., Prunier, F., Ravingerova, T., Serban, A., Slagsvold, K., van Royen, N., Turan, B., Vendelin, M., Walsh, S., Zidar, N., Yellon, D., on behalf ofthe European Union-CARDIOPROTECTION COST ACTION CA16225.
• مؤلفون آخرون: DUKE-NUS MEDICAL SCHOOL
• التنسيق: Review
• منشور في: Springer Science and Business Media Deutschland GmbH 2022
• الموضوعات: Cardioprotection; Drug development; Infarction; Ischemia; Reperfusion
• الوصول للمادة أونلاين: https://scholarbank.nus.edu.sg/handle/10635/232890
• المؤسسة: National University of Singapore

10.1007/s00395-021-00893-5